SCHEMBL22793979

SCHEMBL22793979

Cc1ccc2c(c1)n(C)c(=O)n2C1CCCNC1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DDB1 Q16531 3/20 0.45
▸ CRBN Q96SW2 3/20 0.45
▸ PIK3CA P42336 4/20 0.36
▸ PRKDC P78527 4/20 0.36
▸ MTOR P42345 3/20 0.36
▸ DRD2 P14416 1/20 0.36
▸ SLC6A4 P31645 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ HPD P32754 2/20 0.35
▸ KDM4E B2RXH2 2/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ MAPK14 Q16539 1/20 0.34
▸ GAA P10253 1/20 0.33
▸ CHRM2 P08172 1/20 0.33
▸ CHRM4 P08173 1/20 0.33
▸ CHRM5 P08912 1/20 0.33
▸ CHRM1 P11229 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29347183 0.96 DDB1 (0.44) DDB1CRBNPIK3CAPRKDCMTOR
SCHEMBL24669929 0.84 DDB1 (0.43) DDB1CRBNDRD2SLC6A4MAPT
SCHEMBL26217534 0.84 DDB1 (0.63) DDB1CRBNPIK3CAPRKDCMTOR
SCHEMBL31748074 0.82 DDB1 (0.43) DDB1CRBNPIK3CAPRKDCMTOR
SCHEMBL29347184 0.82 DDB1 (0.46) DDB1CRBNPIK3CAPRKDCMTOR
SCHEMBL25005567 0.80 DDB1 (0.44) DDB1CRBNPIK3CATP53MAPT
SCHEMBL29346392 0.80 DDB1 (0.61) DDB1CRBNPIK3CAPRKDCMTOR
SCHEMBL24029813 0.80 CRBN (0.72) DDB1CRBNALDH1A1CHRM2
SCHEMBL23945499 0.80 CRBN (0.72) DDB1CRBNALDH1A1CHRM2
SCHEMBL20845661 0.80 CRBN (0.72) DDB1CRBNALDH1A1CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020251971-A1 SMARCA DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2020-12-17 — — WO disclosed
Send feedback